Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Mobile Text Messaging on Follow Up Rates After Discharge From the Pediatric Emergency Department

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03674879
Recruitment Status : Withdrawn (PI left facility)
First Posted : September 18, 2018
Last Update Posted : September 18, 2018
Sponsor:
Information provided by (Responsible Party):
New York City Health and Hospitals Corporation

Brief Summary:
To compare the effectiveness of text message versus voice call as a method of contact for providing results of diagnostic tests and assuring ongoing care from the pediatric emergency department.

Condition or disease Intervention/treatment Phase
Duty to Recontact Other: Text Message Not Applicable

Detailed Description:
The investigators plan to conduct a prospective randomized controlled trial to compare two means of contacting patients and their caregivers after discharge from the emergency department in order to provide results of tests: text messaging (intervention group) vs. telephone call (standard group).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Impact of Mobile Text Messaging on Follow Up Rates After Discharge From the Pediatric Emergency Department
Study Start Date : September 2016
Estimated Primary Completion Date : August 2017
Estimated Study Completion Date : December 2017

Arm Intervention/treatment
No Intervention: Phone Call
Follow up contact is attempted via phone call.
Experimental: Text Message
Follow up contact is attempted via text message.
Other: Text Message
Patient contact attempted with text message.




Primary Outcome Measures :
  1. Number of phone call or text message attempts to successful contact with study participant [ Time Frame: Within 2 weeks. ]
    A study practitioner will make one attempt per business day to contact the patient or caregiver to provide test results and arrange follow-up care; the method will be determined by the study arm to which the participant is assigned. Participants in the standard practice control arm will receive a telephone call. If a call is not answered, a voice message will be left instructing the patient/parent to call the Pediatric Follow-Up Office. Participants in the intervention arm will receive a text message using the same script. A successful contact will be recorded when a practitioner speaks directly to the patient or parent/guardian via phone.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • patients under the age of 18 who have had diagnostic testing without finalized results prior to discharge from the emergency department

Exclusion Criteria:

  • Admitted patients
  • Patients transferred to another facility
  • Patients with critical values as results
  • Do not have devices that can receive phone and text messages
  • Cannot read English or Spanish

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03674879


Sponsors and Collaborators
New York City Health and Hospitals Corporation
Investigators
Layout table for investigator information
Principal Investigator: Czer Anthoney E Lim, MD Jacobi Medical Center/Albert Einstein College of Medicine
Publications:

Layout table for additonal information
Responsible Party: New York City Health and Hospitals Corporation
ClinicalTrials.gov Identifier: NCT03674879    
Other Study ID Numbers: NYCHHC
First Posted: September 18, 2018    Key Record Dates
Last Update Posted: September 18, 2018
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by New York City Health and Hospitals Corporation:
Follow Up
Text Messaging
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Disease Attributes
Pathologic Processes